Inhibition of acid sphingomyelinase reduces reactive astrocyte secretion of mitotoxic extracellular vesicles and improves Alzheimer’s disease pathology in the 5xFAD mouse. The gene discussed is SMPD1; the disease is early-onset autosomal dominant Alzheimer disease.